Genetic Signatures

53 NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR ENDED 30 JUNE 2021 34 Note 12: Right of use assets - leases Consolidated 2021 2020 $’000s $’000s (i) Amounts recognised in the statement of financial position Right of use assets Buildings 385 728 Equipment 4 6 389 734 Lease liabilities Current 334 313 Non-current 65 428 399 741 (ii) Amounts recognised in the statement of profit or loss Amortisation charge of right of use assets Buildings 344 303 Equipment 2 2 346 305 Interest expense (included in finance costs) 36 33 Expenses related to short-term leases (included in other expenses) 189 94 Note 13: Trade and other payables Consolidated 2021 2020 $’000s $’000s Current – unsecured Trade creditors 2,755 1,779 Other creditors 597 589 3,352 2,368 Note 14: Provisions Consolidated 2021 2020 $’000s $’000s Current Employee benefits 938 657 Non-Current Employee benefits 18 20 Notes to the Financial Statements for the financial year ended 30 June 2021